FI861006A - Foerfarande foer framstaellning av farmaceutiskt aktiva etrar. - Google Patents

Foerfarande foer framstaellning av farmaceutiskt aktiva etrar. Download PDF

Info

Publication number
FI861006A
FI861006A FI861006A FI861006A FI861006A FI 861006 A FI861006 A FI 861006A FI 861006 A FI861006 A FI 861006A FI 861006 A FI861006 A FI 861006A FI 861006 A FI861006 A FI 861006A
Authority
FI
Finland
Prior art keywords
etrar
farmaceutiskt
aktiva
foerfarande foer
foer framstaellning
Prior art date
Application number
FI861006A
Other languages
English (en)
Other versions
FI861006A0 (fi
Inventor
John Sidney Davies
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858506381A external-priority patent/GB8506381D0/en
Priority claimed from GB858507626A external-priority patent/GB8507626D0/en
Priority claimed from GB868600553A external-priority patent/GB8600553D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of FI861006A0 publication Critical patent/FI861006A0/fi
Publication of FI861006A publication Critical patent/FI861006A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI861006A 1985-03-12 1986-03-11 Foerfarande foer framstaellning av farmaceutiskt aktiva etrar. FI861006A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB858506381A GB8506381D0 (en) 1985-03-12 1985-03-12 Chemical compounds
GB858507626A GB8507626D0 (en) 1985-03-23 1985-03-23 Chemical compounds
GB868600553A GB8600553D0 (en) 1986-01-10 1986-01-10 Chemical compounds

Publications (2)

Publication Number Publication Date
FI861006A0 FI861006A0 (fi) 1986-03-11
FI861006A true FI861006A (fi) 1986-09-13

Family

ID=27262619

Family Applications (1)

Application Number Title Priority Date Filing Date
FI861006A FI861006A (fi) 1985-03-12 1986-03-11 Foerfarande foer framstaellning av farmaceutiskt aktiva etrar.

Country Status (13)

Country Link
US (1) US4847242A (fi)
EP (1) EP0201166B1 (fi)
KR (1) KR870007196A (fi)
AU (1) AU5448886A (fi)
DE (1) DE3668894D1 (fi)
DK (1) DK109886A (fi)
ES (1) ES552858A1 (fi)
FI (1) FI861006A (fi)
GR (1) GR860655B (fi)
HU (1) HUT42502A (fi)
JO (1) JO1484B1 (fi)
NO (1) NO860901L (fi)
PT (1) PT82162B (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharma Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
GB8729369D0 (en) * 1987-12-16 1988-01-27 Beecham Group Plc Chemical compounds
US5075289A (en) * 1988-06-07 1991-12-24 Abbott Laboratories 9-r-azacyclic erythromycin antibiotics
US5302705A (en) * 1989-10-07 1994-04-12 Taisho Pharmaceutical Co., Ltd. 6-O-methylerythromycin a oxime derivatives
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5872229A (en) 1995-11-21 1999-02-16 Abbott Laboratories Process for 6-O-alkylation of erythromycin derivatives
US5929219A (en) 1997-09-10 1999-07-27 Abbott Laboratories 9-hydrazone and 9-azine erythromycin derivatives and a process of making the same
AR023264A1 (es) * 1999-04-08 2002-09-04 Hokuriku Pharmaceutical Derivados de eritromicina
US6673774B2 (en) 2001-12-03 2004-01-06 Enanta Pharmaceuticals, Inc. 11-O-substituted macrolides and their descladinose derivatives
US6750204B2 (en) * 2002-06-25 2004-06-15 Enanta Pharmaceuticals, Inc. 11-C-substituted ketolides
US6812216B2 (en) * 2002-06-25 2004-11-02 Enanta Pharmaceuticals, Inc. 11-C-substituted derivatives of clarithromycin
WO2005067919A1 (en) * 2003-12-24 2005-07-28 Enanta Pharmaceuticals, Inc. 11-csubsituted erythromycin derivatives
US9593140B2 (en) * 2011-11-25 2017-03-14 Bayer Intellectual Property Gmbh Antibacterial tylosin derivatives and methods for their preparation

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2653899A (en) 1952-04-14 1953-09-29 Lilly Co Eli Erythromycin, its salts, and method of preparation
US2761859A (en) 1953-01-14 1956-09-04 Abbott Lab Aqueous soluble salts of erythromycin
US2852429A (en) 1953-08-03 1958-09-16 Lilly Co Eli Antibiotic salts and preparation thereof
US2862921A (en) 1953-08-13 1958-12-02 Upjohn Co Erythromycin esters
US2993833A (en) 1958-07-02 1961-07-25 Lilly Co Eli Erythromycin esters
GB1100504A (en) 1967-08-16 1968-01-24 Pliva Pharm & Chem Works Erythromycin oxime and 9-amino-3-o-cladinosyl-5-o-desosaminyl-6,11,12-trihydroxy-2,4,6,8,10,12-hexamethylpentadecane-13-olide
GB1341022A (en) * 1970-04-13 1973-12-19 Lilly Industries Ltd Erythromycylamine compounds
US3681326A (en) 1971-01-11 1972-08-01 Abbott Lab 9-substituted erythromycin a and b oximes
US3869445A (en) 1973-05-03 1975-03-04 Abbott Lab 4{41 -O-sulfonyl erythromycin-9-O-oxime derivatives
US3836519A (en) 1973-05-04 1974-09-17 Abbott Lab Sulfonyl derivatives of erythromycin
US3884904A (en) * 1973-06-21 1975-05-20 Abbott Lab 11-Substituted erythromycin B derivatives
US3884903A (en) 1973-06-21 1975-05-20 Abbott Lab 4{41 -Deoxy-4{41 -oxoerythromycin B derivatives
US3842069A (en) 1973-06-21 1974-10-15 Abbott Lab 4"-deoxy-4"-oxoerythromycin b derivatives
AT342770B (de) 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DK139522C (da) * 1975-04-07 1979-08-20 Thomae Gmbh Dr K Analogifremgangsmaade til fremstilling af 9-iminoalkylamino-erythromyciner eller syreadditionssalte deraf
US4063014A (en) 1975-06-12 1977-12-13 Abbott Laboratories 4"-O-sulfonyl erythromycin-9-O-oxime derivatives
US4150220A (en) 1977-02-04 1979-04-17 Pfizer Inc. Semi-synthetic 4"-erythromycin A derivatives
FR2473525A1 (fr) 1980-01-11 1981-07-17 Roussel Uclaf Nouvelles oximes derivees de l'erythromycine, leur procede de preparation et leur application comme medicaments
US4331803A (en) 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS5849396A (ja) 1981-09-07 1983-03-23 Toyo Jozo Co Ltd ４″−デオキシ−１４員環マクロライド抗生物質
JPS5896095A (ja) 1981-11-30 1983-06-07 Taisho Pharmaceut Co Ltd １１−ｏ−アルキルエリスロマイシンａ誘導体
JPS5896097A (ja) 1981-12-01 1983-06-07 Taisho Pharmaceut Co Ltd エリスロマイシンｂ誘導体
US4382086A (en) 1982-03-01 1983-05-03 Pfizer Inc. 9-Dihydro-11,12-ketal derivatives of erythromycin A and epi-erythromycin A
JPS60214796A (ja) 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd ６−０−メチルエリスロマイシン類の製法

Also Published As

Publication number Publication date
EP0201166B1 (en) 1990-02-07
FI861006A0 (fi) 1986-03-11
PT82162B (en) 1987-08-06
EP0201166A1 (en) 1986-11-12
HUT42502A (en) 1987-07-28
NO860901L (no) 1986-09-15
US4847242A (en) 1989-07-11
PT82162A (en) 1986-04-01
JO1484B1 (en) 1988-03-10
ES552858A1 (es) 1987-11-01
GR860655B (en) 1986-07-11
DK109886A (da) 1986-09-13
DE3668894D1 (en) 1990-03-15
KR870007196A (ko) 1987-08-17
AU5448886A (en) 1986-09-18
DK109886D0 (da) 1986-03-10

Similar Documents

Publication Publication Date Title
FI861395A (fi) Foerfarande foer framstaellning av hyaluronsyrasalt.
FI864193A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva foereningar.
FI873595A (fi) Foerfarande foer tillverkning av ythylsa foer skivcylinder avsedd foer tryckaendamaol.
FI850004A0 (fi) Foerfarande foer identifiering av nukleinsyror.
FI860058A0 (fi) Foerfarande foer framstaellning av amider anvaendande mikroorganismer.
FI854732A (fi) Foerfarande foer saenkning av svartlutens viskositet.
FI863776A0 (fi) Foerfarande foer framstaellning av 7-aminomitosanderivat.
FI861006A0 (fi) Foerfarande foer framstaellning av farmaceutiskt aktiva etrar.
FI870620A0 (fi) Foerfarande foer framstaellning av koncentrerade emulsionspolymerater.
FI865215A0 (fi) Efterbehandlingsfoerfarande av en jaerngjutningssmaelta.
FI862973A0 (fi) Mikrobiologisk framstaellning av polyfruktos.
FI863100A (fi) Ringformig tryckluftshammare foer borrande av haol.
FI873538A (fi) Foerfarande foer framstaellning av kvaevekonstgoedsel.
FI850208L (fi) Foerfarande foer styrning av alkaliska cellulosakok.
FI862831A0 (fi) Foerfarande foer framstaellning av terbiumaktiverade yttriumsilikatlysaemnen.
FI861237A0 (fi) Foerfarande foer framstaellning av klordioxid.
FI863468A0 (fi) Foerfarande foer foerbraenning av indunstad avlut.
FI852727A0 (fi) Anordning foer framstaellning av plastroer.
FI850421A0 (fi) Foerfarande foer framstaellning av eldfasta tegelprodukter.
FI850420A0 (fi) Foerfarande foer maetning av fjaerrvaermefoerbrukning.
FI850102A0 (fi) Stoedanordning foer uppoevningsanlaeggning av en oegon-hand-koordination.
FI850059A0 (fi) Foerfarande foer framstaellning av en hylsa.
FI850031A0 (fi) Foerfarande foer anaerob rengoering av avfallsvatten.
FI850120L (fi) Automatiseringsmetod av glasboejningsung.
FI850333A0 (fi) Anvaendning av torvaska.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: BEECHAM GROUP LTD